Patent ID: 8758761

Claim:
A method for treating type 1 diabetes wherein said method comprises administering, to a patient in need of such treatment, a combination therapy, wherein the combination therapy consists of administering anti-thymocyte globulin (ATG) and granulocyte colony-stimulating factor (G-CSF); and optionally, one or more additional agents selected from stem cells, agents that reduce a pathological autoimmune response, exenatide, DPPIV inhibitors, EGF, INGAP, a local cytokine, alpha-1 antitrypsin (AAT), vitamin D, anti-oxidants, anti-inflammatory agents, glulisine, glucagons, modulators of cytokines, anti-apoptotic molecules, exendin-4, carriers, adjuvants, binders, diluents, excipients, lubricants, glidants, flavoring agents, preservatives, coloring agents, chelating agents, buffers, and agents for the adjustment of tonicity.